Serious herpes zoster in rheumatoid arthritis under anti-interleukin-6 receptor antibody

被引：10
作者：
Kubandova, Zuzana [1 ]
Mathieu, Sylvain [1 ,2 ]
Pourtier, Claire [1 ,2 ]
Soubrier, Martin [1 ,2 ]
机构：
[1] Gabriel Montpied Hosp, Dept Rheumatol, F-63003 Clermont Ferrand, France
[2] Univ Clermont 1, Dept Rheumatol, Gabriel Montpied Hosp, F-63000 Clermont Ferrand, France
来源：
JOINT BONE SPINE | 2010年 / 77卷 / 06期
关键词：
Rheumatoid arthritis; Biotherapy; Tocilizumab; Herpes zoster; INADEQUATE RESPONSE; CONTROLLED-TRIAL; DISEASE-ACTIVITY; DOUBLE-BLIND; TOCILIZUMAB; INHIBITION; METHOTREXATE; MONOTHERAPY; THERAPY;
D O I：
10.1016/j.jbspin.2010.07.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：623 / 624
页数：3
相关论文
共 50 条
  • [21] Serum Proteome Analysis in Patients with Rheumatoid Arthritis Receiving Therapy with Tocilizumab: An Anti-Interleukin-6 Receptor Antibody
    Yanagida, Mitsuaki
    Kawasaki, Mikiko
    Fujishiro, Maki
    Miura, Masako
    Ikeda, Keigo
    Nozawa, Kazuhisa
    Kaneko, Hiroshi
    Morimoto, Shinji
    Takasaki, Yoshinari
    Ogawa, Hideoki
    Takamori, Kenji
    Sekigawa, Iwao
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [22] IL-6 Signaling and its Blockade with a Humanized Anti-Interleukin-6 Receptor Antibody in Rheumatoid Arthritis: Advent of a New and Innovative Therapeutic Drug, Tocilizumab
    Ohsugi, Yoshiyuki
    Kishimoto, Tadamitsu
    CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (04) : 288 - 300
  • [23] The Efficacy and Safety of Clazakizumab, an Anti-Interleukin-6 Monoclonal Antibody, in a Phase IIb Study of Adults With Active Psoriatic Arthritis
    Mease, Philip J.
    Gottlieb, Alice B.
    Berman, Alberto
    Drescher, Edit
    Xing, Jun
    Wong, Robert
    Banerjee, Subhashis
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (09) : 2163 - 2173
  • [24] Role of Interleukin 6 Inhibitors in the Management of Rheumatoid Arthritis
    Yip, Ronald Man Lung
    Yim, Cheuk Wan
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (08) : E516 - E524
  • [25] Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis
    Shima, Yoshihito
    Tomita, Tetsuya
    Ishii, Taeko
    Morishima, Atsuyoshi
    Maeda, Yuichi
    Ogata, Atsushi
    Kishimoto, Tadamitsu
    Tanaka, Toshio
    MODERN RHEUMATOLOGY, 2011, 21 (04) : 436 - 439
  • [26] Successful Treatment of Reactive Arthritis With a Humanized Anti-Interleukin-6 Receptor Antibody, Tocilizumab
    Tanaka, Toshio
    Kuwahara, Yusuke
    Shima, Yoshihito
    Hirano, Toru
    Kawai, Mari
    Ogawa, Masako
    Arimitsu, Junsuke
    Hagihara, Keisuke
    Narazaki, Masashi
    Ogata, Atsushi
    Kawase, Ichiro
    Kishimoto, Tadamitsu
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (12): : 1762 - 1764
  • [27] Anti-Interleukin-6 Receptor Antibody Treatment in Inflammatory Autoimmune Diseases
    Ding, Changhai
    Jones, Graeme
    REVIEWS ON RECENT CLINICAL TRIALS, 2006, 1 (03) : 193 - 200
  • [28] Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
    Tanaka, Toshio
    Narazaki, Masashi
    Kishimoto, Tadamitsu
    FEBS LETTERS, 2011, 585 (23) : 3699 - 3709
  • [29] Systematic Review of Tocilizumab for Rheumatoid Arthritis: A New Biologic Agent Targeting the Interleukin-6 Receptor
    Navarro-Millan, Iris
    Singh, Jasvinder A.
    Curtis, Jeffrey R.
    CLINICAL THERAPEUTICS, 2012, 34 (04) : 788 - 802
  • [30] Tocilizumab: a novel humanized anti-interleukin 6 receptor antibody for the treatment of patients with rheumatoid arthritis
    Alten, Rieke
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2011, 3 (03) : 133 - 149
12345